Product Program year 2025 Source: CMS Open Payments

Dawnzera

Drug Pulmonology & Immunology

NDC 71860-103-01

Open in the dashboard

General payments

$694,875

3,072 payments

Research payments

$0

0 payments

Through program year 2025, $694,875 in general payments and $0 in research payments were reported against Dawnzera (Pulmonology & Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $694,875 3,072

Breakdown

Who paid General payments · program year 2025
  1. Ionis Pharmaceuticals, Inc. $694,875 3,072 payments
Top recipients General payments · program year 2025
  1. Raffi Tachdjian Allergy & Immunology · Santa Monica, CA $111,178 16% · 75 payments
  2. Autumn Burnette Allergy & Immunology · Washington, DC $30,971 4% · 24 payments
  3. H James Wedner Allergy & Immunology · Saint Louis, MO $30,778 4% · 18 payments
  4. Steve Dorman Allergy & Immunology · Jacksonville, FL $24,242 3% · 31 payments
  5. David Kaufman Allergy & Immunology · Shreveport, LA $22,436 3% · 23 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Allergy & Immunology $455,559 67% · 659 practitioners
  2. Allergy & Immunology Internal Medicine $94,736 14% · 64 practitioners
  3. Allergy Allergy & Immunology $71,976 11% · 114 practitioners
  4. Pediatric Allergy/Immunology Pediatrics $14,692 2% · 24 practitioners
  5. Internal Medicine $14,017 2% · 35 practitioners

The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $171,198 25% · 220 recipients
  2. Florida $61,550 9% · 122 recipients
  3. North Carolina $41,317 6% · 69 recipients
  4. Louisiana $37,521 5% · 25 recipients
  5. Maryland $32,609 5% · 42 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,072 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record